IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $1.14 billion. The enterprise value is $1.08 billion.
| Market Cap | 1.14B |
| Enterprise Value | 1.08B |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | Feb 23, 2026 |
Share Statistics
IRMD has 12.78 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Current Share Class | 12.78M |
| Shares Outstanding | 12.78M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 35.31% |
| Owned by Institutions (%) | 60.10% |
| Float | 8.27M |
Valuation Ratios
The trailing PE ratio is 50.74 and the forward PE ratio is 46.41.
| PE Ratio | 50.74 |
| Forward PE | 46.41 |
| PS Ratio | 13.54 |
| Forward PS | 12.11 |
| PB Ratio | 12.00 |
| P/TBV Ratio | 12.44 |
| P/FCF Ratio | 66.06 |
| P/OCF Ratio | 45.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.69, with an EV/FCF ratio of 63.09.
| EV / Earnings | 48.22 |
| EV / Sales | 12.93 |
| EV / EBITDA | 39.69 |
| EV / EBIT | 41.46 |
| EV / FCF | 63.09 |
Financial Position
The company has a current ratio of 7.98
| Current Ratio | 7.98 |
| Quick Ratio | 6.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 24.78% and return on invested capital (ROIC) is 48.60%.
| Return on Equity (ROE) | 24.78% |
| Return on Assets (ROA) | 15.78% |
| Return on Invested Capital (ROIC) | 48.60% |
| Return on Capital Employed (ROCE) | 26.52% |
| Weighted Average Cost of Capital (WACC) | 10.41% |
| Revenue Per Employee | $504,904 |
| Profits Per Employee | $135,422 |
| Employee Count | 166 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, IRMD has paid $5.88 million in taxes.
| Income Tax | 5.88M |
| Effective Tax Rate | 20.74% |
Stock Price Statistics
The stock price has increased by +70.47% in the last 52 weeks. The beta is 1.12, so IRMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | +70.47% |
| 50-Day Moving Average | 98.29 |
| 200-Day Moving Average | 85.24 |
| Relative Strength Index (RSI) | 33.98 |
| Average Volume (20 Days) | 95,678 |
Short Selling Information
The latest short interest is 499,380, so 3.91% of the outstanding shares have been sold short.
| Short Interest | 499,380 |
| Short Previous Month | 491,595 |
| Short % of Shares Out | 3.91% |
| Short % of Float | 6.04% |
| Short Ratio (days to cover) | 6.28 |
Income Statement
In the last 12 months, IRMD had revenue of $83.81 million and earned $22.48 million in profits. Earnings per share was $1.75.
| Revenue | 83.81M |
| Gross Profit | 64.32M |
| Operating Income | 26.15M |
| Pretax Income | 28.36M |
| Net Income | 22.48M |
| EBITDA | 27.31M |
| EBIT | 26.15M |
| Earnings Per Share (EPS) | $1.75 |
Balance Sheet
The company has $51.16 million in cash and n/a in debt, with a net cash position of $51.16 million or $4.00 per share.
| Cash & Cash Equivalents | 51.16M |
| Total Debt | n/a |
| Net Cash | 51.16M |
| Net Cash Per Share | $4.00 |
| Equity (Book Value) | 94.62M |
| Book Value Per Share | 7.40 |
| Working Capital | 71.02M |
Cash Flow
In the last 12 months, operating cash flow was $24.95 million and capital expenditures -$7.77 million, giving a free cash flow of $17.18 million.
| Operating Cash Flow | 24.95M |
| Capital Expenditures | -7.77M |
| Depreciation & Amortization | 1.17M |
| Net Borrowing | n/a |
| Free Cash Flow | 17.18M |
| FCF Per Share | $1.34 |
Margins
Gross margin is 76.75%, with operating and profit margins of 31.20% and 26.82%.
| Gross Margin | 76.75% |
| Operating Margin | 31.20% |
| Pretax Margin | 33.84% |
| Profit Margin | 26.82% |
| EBITDA Margin | 32.59% |
| EBIT Margin | 31.20% |
| FCF Margin | 20.50% |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 0.90%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 0.90% |
| Dividend Growth (YoY) | 95.16% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 69.14% |
| Buyback Yield | -0.55% |
| Shareholder Yield | 0.35% |
| Earnings Yield | 1.98% |
| FCF Yield | 1.51% |
Analyst Forecast
The average price target for IRMD is $116.00, which is 30.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $116.00 |
| Price Target Difference | 30.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 38.78 and a Piotroski F-Score of 5.
| Altman Z-Score | 38.78 |
| Piotroski F-Score | 5 |